Anelyse de Moura dos Santos

Immune checkpoint inhibitors and the clinical management of immune-related toxicities

Immune checkpoint inhibitors have expanded the treatment of solid and hematologic malignancies, but the same release of inhibitory T-cell signaling can provoke inflammatory injury in almost any organ. This narrative critical review examines how immune-related adverse events should be recognized, differentiated from com...